Luhua Wang

Oct 27, 2024 | analyticalsciencejournals.onlinelibrary.wiley.com | Jianrong Wang |Luhua Wang |Hongfang Zhao |Hongxia Li

Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Filename Description elan202400303-s1-SI_1.docx20.7 KB Supplementary

Apr 25, 2024 | pubs.rsc.org | Jianrong Wang |Luhua Wang |Yi Ren |Hongfang Zhao

Synthesis of N-GQDs/CuS/Cv-CNNs hydrogels and their performance in hexavalent chromium wastewater treatment Hydrogel is a three-dimensional structural body with a polymer network that effectively absorbs and stabilizes a wide range of small molecules and ions, thereby reducing the precipitation of metal ions from the matrix.

Dec 15, 2023 | pubs.rsc.org | Luhua Wang |Yi Ren |Hongfang Zhao |Hongxia Li

Synergistic purification of chromium-containing wastewater via adsorption-photocatalysis induced by multiple defect-containing CuS/Cv-CNNs† To address the water pollution problem caused by hexavalent chromium, this study took advantage of a multi-defect adsorption mechanism and constructed a multiple defect-containing type-II heterojunction material, CuS/Cv-CNNs. This material has simultaneous sulfur vacancies, copper vacancies, and carbon vacancies, which were used to accelerate the removal...

Jun 8, 2023 | frontiersin.org | Shandong Academy |Shandong Normal |Huadong Wang |Luhua Wang

1 IntroductionEsophageal cancer (EC) is one of the most common malignancies, with a global incidence of 3.2% (1). It ranks seventh among all malignant tumors in terms of commonality, has a mortality rate of 5.3%, ranking sixth, and has a 5-year survival rate of only 20% (2). For patients who refuse surgery or who have locally advanced EC that cannot be resected, radiotherapy is one of the best treatment options (3, 4).